Plasma clearance of the radiopharmaceutical can be directly measu

Plasma clearance of the radiopharmaceutical can be directly measured from serial plasma samples, as in the horse, or by measuring changes in cardiac blood pool activity by region of interest analysis of images. The objective of this paper is to present a summary of the reported applications of hepatobiliary scintigraphy in veterinary medicine. Semin Nucl Med 44:15-23 (C) 2014 Elsevier Inc. All rights reserved.”
“Surgery for gastrointestinal stromal tumor (GIST) at the duodenojejunal junction is a technically challenging and difficult procedure because of the anatomical complexity. When it comes to laparoscopic surgery, it is more challenging than open surgery.

This study aimed to introduce our laparoscopic procedure Pevonedistat and to evaluate its clinical implication by comparing with open procedures. Between 2003 and 2013, 19 patients underwent segmental resection for a GIST at the duodenojejunal junction: laparoscopic segmental resection with side-to-side duodenojejunostomy (n = 8) and open surgery (n = 11). Clinicopathological findings, operation details, and postoperative outcomes were compared. Both groups were comparable in demographics and clinicopathological characteristics. Postoperative hospital stay of the laparoscopic group (6.3 days) was significantly shorter than the open group (15.7 days, P = 0.008) while no significant Nirogacestat in vivo differences

were observed regarding estimated blood loss, operation time, and morbidity. All patients in both groups underwent curative resection without operative mortality. Two patients experienced recurrence after open surgery whereas none of the patients after laparoscopic duodenojejunostomy had recurrence with a median follow-up period of 36 selleck screening library months. Laparoscopic segmental resection with side-to-side duodenojejunostomy for a GIST at the duodenojejunal junction is a safe, feasible, and effective alternative to open approach, providing benefits of minimally invasive surgery.”
“Biofuels have great potential as low-carbon transportation fuel

alternatives and can be essentially drop-in fuels for existing fossil-fuel-based transportation infrastructures. Thus, the incentives for biofuel development are large but there are a number of issues: competition with food, land use, fresh water use, economics in comparison to fossil fuels, and achievable reduction in carbon footprint in comparison to other transportation fuel options. This paper focuses on utilization of anthropogenic CO2 from power plants in advanced biofuel production systems and the integration of those systems with various power plant designs. In doing so, the boundary of the life cycle analysis is expanded to include the power plant CO2 source, considering specifically natural gas, pulverized coal, supercritical coal, and IGCC (integrated gasification combined cycle) options.

Comments are closed.